BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Atomwise

Atomwise logo

Founded
2012
Geography
United States of America based
Funding
$174.345 M

Atomwise uses Deep Learning Neural Networks to help discover new medicines. Atomwise achieves the world’s best results for new drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise predicts drug candidates for pharmaceutical companies, startups, and research institutions.

Technologies

AI Companies (Drug Discovery)   Pharmaceutical and Drug Discovery  


Posts Mentioning This Company

Biopharma Insights
Biopharma Insights
White Papers And Industry Reports
Biopharma Insights
Biopharma Insights

R&D Platform

AtomNet is the first drug discovery algorithm to use a deep convolutional neural network. It excels at understanding complex concepts as a combination of smaller and smaller pieces of information. AtomNet has been predicting new potential treatments for two years. It has already explored questions in cancer, neurological diseases, antivirals, antiparasitics, and antibiotics.


AtomNet

Drug design with convolutional neural networks

Read more

Pipelines

No pipelines published yet

Products

 

Services

No services posted yet